NEW YORK (GenomeWeb News) — Insilicos has been awarded a grant from the National Institutes of Health in order to study a statistical methodology that can be applied to biomedical research, the company said yesterday.

The company will use the roughly $400,000 in funds from the National Institute of General Medical Sciences to continue developing a technique called Least Angle Regression, or LARS, which is used to produce stable predictions from data with a large number of dimensions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.